Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 51-60 of 408 for center for individualized medicine

Edit search filters
  1. Expanded Access Study For The Treatment Of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel

    Jacksonville, FL, Rochester, MN

  2. A Study To Evaluate The Long-Term Effectives On ALS Disease Progression Of BIIB067

    Jacksonville, FL, Rochester, MN

  3. A Study to Evaluate Feasibility of Fractional CO2 Vaginal LASER Therapy for Recurrent Urinary Tract Infection

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  4. A Study To Evaluate CC-98633 To Treat Subjects With Relapsed And/or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. A Study To Evaluate TG4050 In Ovarian Carcinoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Pivotal 1 Study Of ABBV-RGX-314 (Also Known As RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time In Participants With NAMD

    Rochester, MN

  7. Safety And Efficacy Of ALLO-715 And ALLO-647 BCMA Allogenic CAR T Cells In In Adults With Relapsed Or Refractory Multiple Myeloma (UNIVERSAL)

    Rochester, MN

  8. A Study Of JNJ-68284528, A Therapy Directed Against B-Cell Maturation Antigen (BCMA) In Participants With Relapsed Or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. Adipose-Derived Mesenchymal Stem Cells (AMSCs) For Recurrent Glioblastoma

    Jacksonville, FL

  10. A Study to Establish a Platform for Managing Pancreatic Adenocarcinoma Using Patient-derived Tumoroids

    Jacksonville, FL

.

Mayo Clinic Footer